MSL
AQST icon

Mackay Shields LLC’s Aquestive Therapeutics AQST Stock Holding History

Mackay Shields LLC’s Portfolio AQST Stock Details AQST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-16,600
Closed -$115K – 1405
2019
Q1 		$115K Buy
+16,600
New +$116K ﹤0.01% 1358

Other funds holding AQST

BCM
Bratton Capital Management Fort Worth, Texas $40.7M AUM 43.1% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Mackay Shields LLC's AQST Position: Q2 2019 in Review

Mackay Shields LLC sold out of Aquestive Therapeutics (AQST) in Q2 2019, closing a stake of 16,600 shares — an estimated $115K sold.

Mackay Shields LLC first reported a position in AQST in Q1 2019 and held it in 1 quarter. The position peaked at $115K in Q1 2019. 40 funds tracked by Wall St. Rank hold AQST as of Q2 2019.

  • Mackay Shields LLC reported no remaining Aquestive Therapeutics position as of Q2 2019 after selling out during the quarter.
  • Mackay Shields LLC sold 16,600 Aquestive Therapeutics shares in Q2 2019, an estimated $115K.
  • Mackay Shields LLC first reported a position in Aquestive Therapeutics in Q1 2019 and held it in 1 quarter.
  • Mackay Shields LLC's Aquestive Therapeutics position peaked at $115K in Q1 2019.
  • 40 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q2 2019.

Based on Mackay Shields LLC's 13F filing for Q2 2019, filed 13 Aug 2019.